Analyse de l'application KardiaRx pour le 7 août

KardiaRx is a prescription-only clinical application used under the direct supervision of licensed healthcare providers for remote cardiac monitoring and clinical trials. A connection code provided by a licensed healthcare professional is the only way to access KardiaRx. It integrates with the FDA-cleared KardiaMobile 6L hardware to record and transmit 6-lead EKGs to certified technicians and physicians for professional analysis. KardiaRx is not a direct-to-consumer application and does not provide automated self-diagnosis; all medical decisions and interpretations are strictly managed by the licensed healthcare providers. KardiaRx requires a KardiaMobile 6L device and a connection code to record an EKG.  Always consult with your physician before making any medical decision, including altering your use of any drug or treatment. This application acts as a software component / companion to a regulated medical device. In strict compliance with international medical device regulations, global distribution is restricted exclusively to the twenty-five (25) countries where this device has received formal regulatory clearance or authorization. KardiaRx is available for download in Australia, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, India, Italy, Malaysia, Netherlands, Norway, Poland, Portugal, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, United States